Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis

Acta Derm Venereol. 2001 Aug-Sep;81(4):298-300. doi: 10.1080/00015550152572985.

Abstract

A hereditary and an acquired type of C1-esterase inhibitor deficiency have been described. Manifestations characteristic of both forms include recurrent subcutaneous and submucosal angiooedema. Acquired C1-esterase inhibitor deficiency has been observed in association with lymphoproliferative disorders, malignancy, autoimmune diseases and infections. We report on a case with the acquired form of the disease accompanied by leucocytoclastic vasculitis. Treatment with antimalarial agents resulted in complete resolution of symptoms and signs. Furthermore, C1-esterase inhibitor concentration and activity, as well as C1 levels, all returned to normal.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angioedema / drug therapy
  • Angioedema / enzymology*
  • Antimalarials / therapeutic use
  • Chloroquine / therapeutic use
  • Complement C1 Inactivator Proteins / deficiency*
  • Complement System Proteins
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Treatment Outcome
  • Vasculitis, Leukocytoclastic, Cutaneous / drug therapy
  • Vasculitis, Leukocytoclastic, Cutaneous / enzymology*

Substances

  • Antimalarials
  • Complement C1 Inactivator Proteins
  • Hydroxychloroquine
  • Chloroquine
  • Complement System Proteins